Your browser doesn't support javascript.
loading
PhenoMeNal: processing and analysis of metabolomics data in the cloud.
Peters, Kristian; Bradbury, James; Bergmann, Sven; Capuccini, Marco; Cascante, Marta; de Atauri, Pedro; Ebbels, Timothy M D; Foguet, Carles; Glen, Robert; Gonzalez-Beltran, Alejandra; Günther, Ulrich L; Handakas, Evangelos; Hankemeier, Thomas; Haug, Kenneth; Herman, Stephanie; Holub, Petr; Izzo, Massimiliano; Jacob, Daniel; Johnson, David; Jourdan, Fabien; Kale, Namrata; Karaman, Ibrahim; Khalili, Bita; Emami Khonsari, Payam; Kultima, Kim; Lampa, Samuel; Larsson, Anders; Ludwig, Christian; Moreno, Pablo; Neumann, Steffen; Novella, Jon Ander; O'Donovan, Claire; Pearce, Jake T M; Peluso, Alina; Piras, Marco Enrico; Pireddu, Luca; Reed, Michelle A C; Rocca-Serra, Philippe; Roger, Pierrick; Rosato, Antonio; Rueedi, Rico; Ruttkies, Christoph; Sadawi, Noureddin; Salek, Reza M; Sansone, Susanna-Assunta; Selivanov, Vitaly; Spjuth, Ola; Schober, Daniel; Thévenot, Etienne A; Tomasoni, Mattia.
Afiliación
  • Peters K; Leibniz Institute of Plant Biochemistry, Stress and Developmental Biology, Weinberg 3, 06120 Halle (Saale), Germany.
  • Bradbury J; School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
  • Bergmann S; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
  • Capuccini M; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Cascante M; Division of Scientific Computing, Department of Information Technology, Uppsala University, Sweden.
  • de Atauri P; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
  • Ebbels TMD; Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
  • Foguet C; Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
  • Glen R; Department of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
  • Gonzalez-Beltran A; Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
  • Günther UL; Department of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
  • Handakas E; Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB21EW, United Kingdom.
  • Hankemeier T; Oxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
  • Haug K; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
  • Herman S; Department of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
  • Holub P; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, 2333 CC, The Netherlands.
  • Izzo M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
  • Jacob D; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
  • Johnson D; Department of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
  • Jourdan F; BBMRI-ERIC, Graz, Austria.
  • Kale N; Oxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
  • Karaman I; INRA, University of Bordeaux, Plateforme Métabolome Bordeaux-MetaboHUB, 33140 Villenave d'Ornon, France.
  • Khalili B; Oxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
  • Emami Khonsari P; Department of Informatics and Media, Uppsala University, Box 513, 751 20 Uppsala, Sweden.
  • Kultima K; INRA - French National Institute for Agricultural Research, UMR1331, Toxalim, Research Centre in Food Toxicology, Toulouse, France.
  • Lampa S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
  • Larsson A; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St. Mary's Campus, Norfolk Place, W2 1PG, London, United Kingdom.
  • Ludwig C; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
  • Moreno P; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Neumann S; Department of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
  • Novella JA; Department of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
  • O'Donovan C; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
  • Pearce JTM; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
  • Peluso A; National Bioinformatics Infrastructure Sweden, Uppsala University, Uppsala, Sweden.
  • Piras ME; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
  • Pireddu L; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
  • Reed MAC; Leibniz Institute of Plant Biochemistry, Stress and Developmental Biology, Weinberg 3, 06120 Halle (Saale), Germany.
  • Rocca-Serra P; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Deutscher Platz 5e, 04103 Leipzig, Germany.
  • Roger P; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
  • Rosato A; National Bioinformatics Infrastructure Sweden, Uppsala University, Uppsala, Sweden.
  • Rueedi R; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
  • Ruttkies C; Department of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
  • Sadawi N; Department of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
  • Salek RM; Distributed Computing Group, CRS4, Pula, Italy.
  • Sansone SA; Distributed Computing Group, CRS4, Pula, Italy.
  • Selivanov V; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
  • Spjuth O; Oxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
  • Schober D; CEA, LIST, Laboratory for Data Analysis and Systems' Intelligence, MetaboHUB, Gif-Sur-Yvette F-91191, France.
  • Thévenot EA; Magnetic Resonance Center (CERM) and Department of Chemistry, University of Florence and CIRMMP, 50019 Sesto Fiorentino, Florence, Italy.
  • Tomasoni M; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Gigascience ; 8(2)2019 02 01.
Article en En | MEDLINE | ID: mdl-30535405
BACKGROUND: Metabolomics is the comprehensive study of a multitude of small molecules to gain insight into an organism's metabolism. The research field is dynamic and expanding with applications across biomedical, biotechnological, and many other applied biological domains. Its computationally intensive nature has driven requirements for open data formats, data repositories, and data analysis tools. However, the rapid progress has resulted in a mosaic of independent, and sometimes incompatible, analysis methods that are difficult to connect into a useful and complete data analysis solution. FINDINGS: PhenoMeNal (Phenome and Metabolome aNalysis) is an advanced and complete solution to set up Infrastructure-as-a-Service (IaaS) that brings workflow-oriented, interoperable metabolomics data analysis platforms into the cloud. PhenoMeNal seamlessly integrates a wide array of existing open-source tools that are tested and packaged as Docker containers through the project's continuous integration process and deployed based on a kubernetes orchestration framework. It also provides a number of standardized, automated, and published analysis workflows in the user interfaces Galaxy, Jupyter, Luigi, and Pachyderm. CONCLUSIONS: PhenoMeNal constitutes a keystone solution in cloud e-infrastructures available for metabolomics. PhenoMeNal is a unique and complete solution for setting up cloud e-infrastructures through easy-to-use web interfaces that can be scaled to any custom public and private cloud environment. By harmonizing and automating software installation and configuration and through ready-to-use scientific workflow user interfaces, PhenoMeNal has succeeded in providing scientists with workflow-driven, reproducible, and shareable metabolomics data analysis platforms that are interfaced through standard data formats, representative datasets, versioned, and have been tested for reproducibility and interoperability. The elastic implementation of PhenoMeNal further allows easy adaptation of the infrastructure to other application areas and 'omics research domains.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Programas Informáticos / Metabolómica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gigascience Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Programas Informáticos / Metabolómica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gigascience Año: 2019 Tipo del documento: Article País de afiliación: Alemania
...